{"id":320188,"date":"2026-10-21T13:17:04","date_gmt":"2026-10-21T07:47:04","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=320188"},"modified":"2026-10-21T13:17:04","modified_gmt":"2026-10-21T07:47:04","slug":"largecap-stocks-for-1-year-to-watch-multibagger-potential","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/largecap-stocks-for-1-year-to-watch-multibagger-potential\/","title":{"rendered":"4 Largecap Stocks For 1 Year to Watch for Future Multibagger Potential: Divi&#8217;s Labs, BHEL, BSE and Laurus Labs"},"content":{"rendered":"<p style=\"border-left:4px solid #1F4E79;background:#EBF3FB;padding:10px 16px;font-style:italic;\"><em>Divi&#8217;s Labs Rs 9,087. BHEL Rs 427.35. BSE Rs 3,336. Laurus Labs Rs 2,069. Market caps from Rs 1.09 lakh crore to Rs 2.40 lakh crore. Data as of 20 Oct 2026.<\/em><\/p>\n<div style=\"background:#F0F9FF;border-left:4px solid #2E7D32;border-radius:6px;padding:14px 18px;margin:18px 0;\">\n<p style=\"margin:0;color:#1F4E79;font-size:14px;\"><strong>Quick Answer<\/strong><\/p>\n<p style=\"margin:8px 0 0;\">Divi&#8217;s Labs, BHEL, BSE and Laurus Labs are the 4 picks in this stocks for 1 year watchlist, with market caps between Rs 1.09 lakh crore and Rs 2.40 lakh crore. Divi&#8217;s Labs stands out for the largest market cap at Rs 2,39,982 crore, while BHEL offers 20.08% revenue growth in FY26. PE ratios run from 49.55 to 100.10, so compare each one with its industry PE before investing. All figures are as of 20 October 2026.<\/p>\n<\/p><\/div>\n<p>Stocks for 1 year to watch for multibagger potential start with a simple filter: size, a clean financial record and earnings that keep growing. Divi&#8217;s Labs, BHEL, BSE and Laurus Labs meet that test, with market caps from Rs 1.09 lakh crore to Rs 2.40 lakh crore and Divi&#8217;s Labs offering the largest market cap at Rs 2,39,982 crore. Each of these shares gained more than 30 per cent over the past year, and net profit grew by more than 15 per cent in FY26 and by more than 60 per cent in the latest quarter.<\/p>\n<p>This list covers shares with a past-year gain above 30 per cent, FY26 profit growth above 15 per cent, latest-quarter profit growth above 60 per cent and market capitalisation above Rs 1,00,000 crore. Each company has a market cap above Rs 1 lakh crore. Investors screening stocks for 1 year usually begin with size and balance sheet strength, and this list follows the same logic. All figures are as of 20 October 2026 and are drawn from NSE and BSE data and company filings.<\/p>\n<p style=\"margin-top:24px;\"><a href=\"https:\/\/univest.in\/user\/log-in?utm_source=blogs&#038;utm_medium=stocks-for-year\"><strong>Click Here &#8211; Get Free Investment Predictions<\/strong><\/a><\/p>\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_65 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title \" >Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/univest.in\/blogs-2\/largecap-stocks-for-1-year-to-watch-multibagger-potential\/#What_Are_Stocks_For_1_Year_and_Why_Do_They_Attract_Multibagger_Interest\" title=\"What Are Stocks For 1 Year and Why Do They Attract Multibagger Interest?\">What Are Stocks For 1 Year and Why Do They Attract Multibagger Interest?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/univest.in\/blogs-2\/largecap-stocks-for-1-year-to-watch-multibagger-potential\/#Stocks_For_1_Year_at_a_Glance_Price_Market_Cap_PE_and_ROE\" title=\"Stocks For 1 Year at a Glance: Price, Market Cap, PE and ROE\">Stocks For 1 Year at a Glance: Price, Market Cap, PE and ROE<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/univest.in\/blogs-2\/largecap-stocks-for-1-year-to-watch-multibagger-potential\/#Divis_Labs_Debt-to-Equity_of_000\" title=\"Divi&#8217;s Labs: Debt-to-Equity of 0.00\">Divi&#8217;s Labs: Debt-to-Equity of 0.00<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/univest.in\/blogs-2\/largecap-stocks-for-1-year-to-watch-multibagger-potential\/#BHEL_3773_Profit_CAGR_Since_FY22\" title=\"BHEL: 37.73% Profit CAGR Since FY22\">BHEL: 37.73% Profit CAGR Since FY22<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/univest.in\/blogs-2\/largecap-stocks-for-1-year-to-watch-multibagger-potential\/#BSE_7830_Profit_CAGR_Since_FY22\" title=\"BSE: 78.30% Profit CAGR Since FY22\">BSE: 78.30% Profit CAGR Since FY22<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/univest.in\/blogs-2\/largecap-stocks-for-1-year-to-watch-multibagger-potential\/#Laurus_Labs_Revenue_Up_2201_in_FY26\" title=\"Laurus Labs: Revenue Up 22.01% in FY26\">Laurus Labs: Revenue Up 22.01% in FY26<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/univest.in\/blogs-2\/largecap-stocks-for-1-year-to-watch-multibagger-potential\/#Stocks_For_1_Year_Financial_Comparison_on_Growth_and_Margins\" title=\"Stocks For 1 Year: Financial Comparison on Growth and Margins\">Stocks For 1 Year: Financial Comparison on Growth and Margins<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/univest.in\/blogs-2\/largecap-stocks-for-1-year-to-watch-multibagger-potential\/#Institutional_Holding_in_Divis_Labs_BHEL_BSE_and_Laurus_Labs\" title=\"Institutional Holding in Divi&#8217;s Labs, BHEL, BSE and Laurus Labs\">Institutional Holding in Divi&#8217;s Labs, BHEL, BSE and Laurus Labs<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/univest.in\/blogs-2\/largecap-stocks-for-1-year-to-watch-multibagger-potential\/#Risks_to_Weigh_in_Stocks_For_1_Year\" title=\"Risks to Weigh in Stocks For 1 Year\">Risks to Weigh in Stocks For 1 Year<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/univest.in\/blogs-2\/largecap-stocks-for-1-year-to-watch-multibagger-potential\/#How_to_Choose_Between_Stocks_For_1_Year\" title=\"How to Choose Between Stocks For 1 Year\">How to Choose Between Stocks For 1 Year<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/univest.in\/blogs-2\/largecap-stocks-for-1-year-to-watch-multibagger-potential\/#Conclusion\" title=\"Conclusion\">Conclusion<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/univest.in\/blogs-2\/largecap-stocks-for-1-year-to-watch-multibagger-potential\/#Frequently_Asked_Questions_on_Stocks_For_1_Year_to_Watch\" title=\"Frequently Asked Questions on Stocks For 1 Year to Watch\">Frequently Asked Questions on Stocks For 1 Year to Watch<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-13\" href=\"https:\/\/univest.in\/blogs-2\/largecap-stocks-for-1-year-to-watch-multibagger-potential\/#Which_are_the_best_stocks_for_1_year_to_watch_for_multibagger_potential\" title=\"Which are the best stocks for 1 year to watch for multibagger potential?\">Which are the best stocks for 1 year to watch for multibagger potential?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-14\" href=\"https:\/\/univest.in\/blogs-2\/largecap-stocks-for-1-year-to-watch-multibagger-potential\/#Is_BSE_a_good_stock_for_long-term_investors\" title=\"Is BSE a good stock for long-term investors?\">Is BSE a good stock for long-term investors?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-15\" href=\"https:\/\/univest.in\/blogs-2\/largecap-stocks-for-1-year-to-watch-multibagger-potential\/#Can_BHEL_become_a_multibagger_from_here\" title=\"Can BHEL become a multibagger from here?\">Can BHEL become a multibagger from here?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-16\" href=\"https:\/\/univest.in\/blogs-2\/largecap-stocks-for-1-year-to-watch-multibagger-potential\/#What_is_the_market_cap_of_Divis_Labs_BHEL_BSE_and_Laurus_Labs\" title=\"What is the market cap of Divi&#8217;s Labs, BHEL, BSE and Laurus Labs?\">What is the market cap of Divi&#8217;s Labs, BHEL, BSE and Laurus Labs?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-17\" href=\"https:\/\/univest.in\/blogs-2\/largecap-stocks-for-1-year-to-watch-multibagger-potential\/#What_are_the_risks_of_investing_in_stocks_for_1_year\" title=\"What are the risks of investing in stocks for 1 year?\">What are the risks of investing in stocks for 1 year?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-18\" href=\"https:\/\/univest.in\/blogs-2\/largecap-stocks-for-1-year-to-watch-multibagger-potential\/#Why_is_Laurus_Labs_trading_at_a_PE_of_10010\" title=\"Why is Laurus Labs trading at a PE of 100.10?\">Why is Laurus Labs trading at a PE of 100.10?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-19\" href=\"https:\/\/univest.in\/blogs-2\/largecap-stocks-for-1-year-to-watch-multibagger-potential\/#How_much_do_institutions_hold_in_Divis_Labs_BHEL_BSE_and_Laurus_Labs\" title=\"How much do institutions hold in Divi&#8217;s Labs, BHEL, BSE and Laurus Labs?\">How much do institutions hold in Divi&#8217;s Labs, BHEL, BSE and Laurus Labs?<\/a><\/li><\/ul><\/li><\/ul><\/nav><\/div>\n<h2><span class=\"ez-toc-section\" id=\"What_Are_Stocks_For_1_Year_and_Why_Do_They_Attract_Multibagger_Interest\"><\/span><strong>What Are Stocks For 1 Year and Why Do They Attract Multibagger Interest?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Stocks for 1 year are shares where price momentum and earnings momentum are moving together. The four here cover power equipment, pharmaceuticals and a stock exchange.<\/p>\n<p>A one-year view favours companies whose results are improving right now. For stocks for 1 year, recent quarterly growth supports the share price trend. With stocks for 1 year, comparing valuation, growth and balance sheet strength together works better than relying on one number. Every company in the table below passed a rising-profit check, and the figures for stocks for 1 year are complete. Read each company&#8217;s latest results and exchange filings before acting on stocks for 1 year.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Stocks_For_1_Year_at_a_Glance_Price_Market_Cap_PE_and_ROE\"><\/span><strong>Stocks For 1 Year at a Glance: Price, Market Cap, PE and ROE<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Prices are closing prices as of 20 October 2026. BSE combines the lowest PE of the group, 49.55, with the highest return on equity, 37.42%.<\/p>\n<table style=\"border-collapse:collapse;width:100%;margin:16px 0;\">\n<thead>\n<tr>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">Stock<\/th>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">CMP (Rs)<\/th>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">Market Cap (Rs Cr)<\/th>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">PE<\/th>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">Industry PE<\/th>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">ROE<\/th>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">Debt to Equity<\/th>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">52-Week Range (Rs)<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/divislab\/divi's-laboratories-ltd-share-price-today\">Divi&#8217;s Laboratories<\/a><\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">9,087<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">2,39,982<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">82.05<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">36.42<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">15.32%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">0.00<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">5,647.50 to 9,740.00<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/bhel\/bharat-heavy-electricals-ltd-share-price-today\">Bharat Heavy Electricals<\/a><\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">427.35<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">1,51,365<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">52.56<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">45.89<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">10.76%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">0.23<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">229.54 to 464.00<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/bse\/bse-ltd-share-price-today\">BSE Ltd<\/a><\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">3,336<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">1,39,823<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">49.55<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">42.42<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">37.42%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">0.00<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">2,326.10 to 4,446.80<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/lauruslabs\/laurus-labs-ltd-share-price-today\">Laurus Labs<\/a><\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">2,069<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">1,09,143<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">100.10<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">36.42<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">16.77%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">0.48<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">864.70 to 2,085.90<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2><span class=\"ez-toc-section\" id=\"Divis_Labs_Debt-to-Equity_of_000\"><\/span><strong>Divi&#8217;s Labs: Debt-to-Equity of 0.00<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Divi&#8217;s Laboratories makes active pharmaceutical ingredients and intermediates and runs a large custom synthesis business for global drug companies. It reported FY26 revenue of Rs 11,067 crore, up 13.95% year on year, and net profit of Rs 2,568 crore, up 17.21%. Revenue has compounded at 5.09% a year since FY22. Operating margin was 36.70% in FY26. The debt-to-equity ratio is 0.00, which keeps interest costs low.<\/p>\n<p>In the June 2026 quarter, revenue rose 24.32% to Rs 3,144 crore and net profit grew 65.50% to Rs 902 crore. The share price has gained 71.04% over five years and 38.43% over the past year. Foreign investors raised their holding from 19.39% in September 2025 to 20.38% in September 2026. The stock trades at a PE of 82.05 against an industry PE of 36.42, with a return on equity of 15.32%.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"BHEL_3773_Profit_CAGR_Since_FY22\"><\/span><strong>BHEL: 37.73% Profit CAGR Since FY22<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Bharat Heavy Electricals is a government-owned maker of power generation, transmission, industrial and transportation equipment. It reported FY26 revenue of Rs 34,589.83 crore, up 20.08% year on year, and net profit of Rs 1,600.26 crore, up 199.73%. Net profit has compounded at 37.73% a year since FY22, while revenue has grown 12.54% a year. Operating margin was 10.18% in FY26. The debt-to-equity ratio is 0.23.<\/p>\n<p>The stock trades at a PE of 52.56 against an industry PE of 45.89. In the September 2026 quarter, revenue rose 24.28% to Rs 9,553.01 crore and net profit grew 118.98% to Rs 820.94 crore. The share price has gained 488.34% over five years and 86.13% over the past year. Domestic institutions raised their holding from 18.62% in September 2025 to 21.88% in September 2026.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"BSE_7830_Profit_CAGR_Since_FY22\"><\/span><strong>BSE: 78.30% Profit CAGR Since FY22<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>BSE Ltd operates one of India&#8217;s two major stock exchanges and earns from trading, listing, data and clearing services. It reported FY26 revenue of Rs 5,148.10 crore, up 59.07% year on year, and net profit of Rs 2,475.30 crore, up 87.94%. Net profit has compounded at 78.30% a year since FY22, while revenue has grown 56.26% a year. Operating margin was 68.39% in FY26. The debt-to-equity ratio is 0.00, which keeps interest costs low.<\/p>\n<p>In the June 2026 quarter, revenue rose 63.41% to Rs 1,706.72 crore and net profit grew 62.15% to Rs 872.66 crore. The share price has gained 2101.66% over five years and 37.49% over the past year. Domestic institutions raised their holding from 13.51% in June 2025 to 24.15% in June 2026. The stock trades at a PE of 49.55 against an industry PE of 42.42, with a return on equity of 37.42%.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Laurus_Labs_Revenue_Up_2201_in_FY26\"><\/span><strong>Laurus Labs: Revenue Up 22.01% in FY26<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Laurus Labs makes active pharmaceutical ingredients and formulations and offers contract development and manufacturing services. It reported FY26 revenue of Rs 6,867.85 crore, up 22.01% year on year, and net profit of Rs 889.85 crore, up 151.08%. Revenue has compounded at 8.53% a year since FY22. Operating margin was 26.90% in FY26. The debt-to-equity ratio is 0.48.<\/p>\n<p>The stock trades at a PE of 100.10 against an industry PE of 36.42, with a return on equity of 16.77%. In the June 2026 quarter, revenue rose 28.83% to Rs 2,035.49 crore and net profit grew 124.73% to Rs 361.99 crore. The share price has gained 221.40% over five years and 137.53% over the past year. Domestic institutions raised their holding from 11.94% in June 2025 to 13.74% in June 2026.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Stocks_For_1_Year_Financial_Comparison_on_Growth_and_Margins\"><\/span><strong>Stocks For 1 Year: Financial Comparison on Growth and Margins<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>The table compares scale and growth across these stocks for 1 year. Latest quarter means the most recent reported quarter for each company, and only metrics that are positive for every company are shown.<\/p>\n<table style=\"border-collapse:collapse;width:100%;margin:16px 0;\">\n<thead>\n<tr>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">Stock<\/th>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">Revenue (Rs Cr)<\/th>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">Net Profit (Rs Cr)<\/th>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">Revenue Growth (YoY)<\/th>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">4-Year Revenue CAGR<\/th>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">Latest Quarter Revenue Growth<\/th>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">Operating Margin (Latest Quarter)<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">Divi&#8217;s Labs<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">11,067<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">2,568<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">13.95%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">5.09%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">24.32%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">42.82%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">BHEL<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">34,589.83<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">1,600.26<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">20.08%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">12.54%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">24.28%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">13.94%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">BSE<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">5,148.10<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">2,475.30<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">59.07%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">56.26%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">63.41%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">77.03%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">Laurus Labs<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">6,867.85<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">889.85<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">22.01%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">8.53%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">28.83%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">31.95%<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p style=\"margin-top:24px;\"><a href=\"https:\/\/univest.in\/screeners\"><strong>Check the Univest Screener for live data on these stocks for 1 year<\/strong><\/a><\/p>\n<h2><span class=\"ez-toc-section\" id=\"Institutional_Holding_in_Divis_Labs_BHEL_BSE_and_Laurus_Labs\"><\/span><strong>Institutional Holding in Divi&#8217;s Labs, BHEL, BSE and Laurus Labs<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Institutional holding shows who is backing these stocks for 1 year alongside the promoter. The table uses the latest reported quarter for each. BSE has the deepest institutional backing, with FII and DII together holding 45.47% as of June 2026. Domestic institutions increased their holding over the past year in BHEL (from 18.62% to 21.88%), BSE (from 13.51% to 24.15%) and Laurus Labs (from 11.94% to 13.74%).<\/p>\n<table style=\"border-collapse:collapse;width:100%;margin:16px 0;\">\n<thead>\n<tr>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">Stock<\/th>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">Promoter<\/th>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">FII<\/th>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">DII<\/th>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">Public<\/th>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">Quarter<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">Divi&#8217;s Labs<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">51.88%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">20.38%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">19.17%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">8.58%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">September 2026<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">BHEL<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">58.17%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">9.94%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">21.88%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">10.02%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">September 2026<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">BSE<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">Nil<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">21.32%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">24.15%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">54.53%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">June 2026<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">Laurus Labs<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">27.47%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">28.00%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">13.74%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">30.78%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">June 2026<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2><span class=\"ez-toc-section\" id=\"Risks_to_Weigh_in_Stocks_For_1_Year\"><\/span><strong>Risks to Weigh in Stocks For 1 Year<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Being careful with stocks for 1 year means looking at what can slow the story as well as what can speed it up. Four points matter most:<\/p>\n<ul>\n<li>Past growth may not repeat.<\/li>\n<li>Share prices can move sharply in either direction.<\/li>\n<li><strong>Valuation:<\/strong> Laurus Labs trades at a PE of 100.10 against an industry PE of 36.42, so earnings need to keep growing to support the price.<\/li>\n<li><strong>Concentration:<\/strong> Holding all 4 names puts the allocation in one sector, so size each position to match your risk appetite.<\/li>\n<\/ul>\n<h2><span class=\"ez-toc-section\" id=\"How_to_Choose_Between_Stocks_For_1_Year\"><\/span><strong>How to Choose Between Stocks For 1 Year<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Picking from stocks for 1 year comes down to four checks, applied in order.<\/p>\n<ol>\n<li>Check balance sheet strength first, and prefer a debt-to-equity ratio below 1 for non-financial companies.<\/li>\n<li>Compare each PE with the industry PE (36.42 to 45.89) and ask whether the growth rate justifies any gap.<\/li>\n<li>Track net profit growth, the operating margin and the return on equity in every quarterly result.<\/li>\n<li>Stagger entries across quarters and review institutional holding every reporting season.<\/li>\n<\/ol>\n<p style=\"margin-top:24px;\"><em>Download the <a href=\"http:\/\/apps.apple.com\/in\/app\/univest-stocks-investment\/id6443753518\" rel=\"nofollow noopener\" target=\"_blank\">Univest iOS App<\/a> or <a href=\"http:\/\/play.google.com\/store\/apps\/details?id=com.univest.capp&#038;hl=en_IN\" rel=\"nofollow noopener\" target=\"_blank\">Univest Android App<\/a> to track Divi&#8217;s Labs, BHEL, BSE and Laurus Labs live prices.<\/em><\/p>\n<h2><span class=\"ez-toc-section\" id=\"Conclusion\"><\/span><strong>Conclusion<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Among stocks for 1 year, Divi&#8217;s Labs stands out for the largest market cap at Rs 2,39,982 crore, BHEL for 20.08% revenue growth in FY26, BSE for the highest return on equity at 37.42% and Laurus Labs for the strongest latest-quarter profit growth at 124.73%. Which one suits a portfolio depends on how much valuation risk it can carry, so staggering entries and reviewing each quarterly result is a sound habit. Investors comparing stocks for 1 year should rank them on growth, financial strength and the price paid, and anyone who wants personalised guidance can consult a SEBI-registered advisor before acting.<\/p>\n<div style=\"background:#CC0000;border-radius:8px;padding:16px 20px;margin:24px 0;\">\n<p style=\"color:#FFFFFF;font-size:13px;line-height:1.7;margin:0;\"><strong style=\"color:#FFFFFF;\">Disclaimer:<\/strong> Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).<\/p>\n<\/p><\/div>\n<h2><span class=\"ez-toc-section\" id=\"Frequently_Asked_Questions_on_Stocks_For_1_Year_to_Watch\"><\/span><strong>Frequently Asked Questions on Stocks For 1 Year to Watch<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"Which_are_the_best_stocks_for_1_year_to_watch_for_multibagger_potential\"><\/span><strong>Which are the best stocks for 1 year to watch for multibagger potential?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Divi&#8217;s Labs, BHEL, BSE and Laurus Labs are the 4 names this list highlights, with market caps of Rs 2,39,982 crore, Rs 1,51,365 crore, Rs 1,39,823 crore and Rs 1,09,143 crore respectively. Divi&#8217;s Labs is notable for the largest market cap at Rs 2,39,982 crore. BHEL stands out for 20.08% revenue growth in FY26. BSE offers the highest return on equity at 37.42%. Laurus Labs brings the strongest latest-quarter profit growth at 124.73%. These are watchlist names for stocks for 1 year, not recommendations, so match each one to your own risk profile and time horizon.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Is_BSE_a_good_stock_for_long-term_investors\"><\/span><strong>Is BSE a good stock for long-term investors?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> BSE has a return on equity of 37.42%, a PE of 49.55 against an industry PE of 42.42 and a market cap of Rs 1,39,823 crore. Net profit has compounded at 78.30% a year since FY22, and FY26 revenue rose 59.07% while June 2026 quarter net profit grew 62.15%. Long-term returns in stocks for 1 year depend on earnings growth and the price paid at entry, so staggering purchases and consulting a SEBI-registered advisor is sensible.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Can_BHEL_become_a_multibagger_from_here\"><\/span><strong>Can BHEL become a multibagger from here?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> BHEL has already gained 488.34% in five years, so another multi-fold move would need sustained earnings growth. A multibagger outcome in stocks for 1 year requires earnings to keep growing faster than the market for several years. Net profit has compounded at 37.73% a year since FY22, and FY26 revenue rose 20.08%. At a PE of 52.56 against an industry PE of 45.89, valuation should be checked against that growth before investing.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_market_cap_of_Divis_Labs_BHEL_BSE_and_Laurus_Labs\"><\/span><strong>What is the market cap of Divi&#8217;s Labs, BHEL, BSE and Laurus Labs?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> As of 20 October 2026, Divi&#8217;s Labs has a market cap of Rs 2,39,982 crore, BHEL has a market cap of Rs 1,51,365 crore, BSE has a market cap of Rs 1,39,823 crore and Laurus Labs has a market cap of Rs 1,09,143 crore. All of them qualify as largecaps. Market cap changes daily with the share price, so check the latest figure on the Univest Screener or on NSE before taking a decision on stocks for 1 year.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_are_the_risks_of_investing_in_stocks_for_1_year\"><\/span><strong>What are the risks of investing in stocks for 1 year?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The main risks are market swings, slower growth than expected and valuations that already reflect good news. Companies with strong balance sheets and steady earnings handle these better. Laurus Labs trades at a PE of 100.10 against an industry PE of 36.42, so earnings growth needs to hold up.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Why_is_Laurus_Labs_trading_at_a_PE_of_10010\"><\/span><strong>Why is Laurus Labs trading at a PE of 100.10?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Laurus Labs&#8217; PE of 100.10 compares with an industry PE of 36.42. The market is paying a premium for a return on equity of 16.77%, latest-quarter profit growth of 124.73% and FY26 revenue growth of 22.01%, which also means the stock is more sensitive if growth slows. Investors in stocks for 1 year who are comfortable with higher valuation risk may prefer to stagger purchases instead of investing in one go.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_much_do_institutions_hold_in_Divis_Labs_BHEL_BSE_and_Laurus_Labs\"><\/span><strong>How much do institutions hold in Divi&#8217;s Labs, BHEL, BSE and Laurus Labs?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> As of the latest reported quarter, FII and DII together hold 39.55% of Divi&#8217;s Labs (20.38% and 19.17%), 31.82% of BHEL (9.94% and 21.88%), 45.47% of BSE (21.32% and 24.15%) and 41.74% of Laurus Labs (28.00% and 13.74%). Rising institutional holding is a useful signal in stocks for 1 year, though it should be read with earnings trends rather than on its own.<\/p>\n<p><script type=\"application\/ld+json\">{\"@context\":\"https:\/\/schema.org\",\"@type\":\"FAQPage\",\"mainEntity\":[{\"@type\":\"Question\",\"name\":\"Which are the best stocks for 1 year to watch for multibagger potential?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Divi's Labs, BHEL, BSE and Laurus Labs are the 4 names this list highlights, with market caps of Rs 2,39,982 crore, Rs 1,51,365 crore, Rs 1,39,823 crore and Rs 1,09,143 crore respectively. Divi's Labs is notable for the largest market cap at Rs 2,39,982 crore. BHEL stands out for 20.08% revenue growth in FY26. BSE offers the highest return on equity at 37.42%. Laurus Labs brings the strongest latest-quarter profit growth at 124.73%. These are watchlist names for stocks for 1 year, not recommendations, so match each one to your own risk profile and time horizon.\"}},{\"@type\":\"Question\",\"name\":\"Is BSE a good stock for long-term investors?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"BSE has a return on equity of 37.42%, a PE of 49.55 against an industry PE of 42.42 and a market cap of Rs 1,39,823 crore. Net profit has compounded at 78.30% a year since FY22, and FY26 revenue rose 59.07% while June 2026 quarter net profit grew 62.15%. Long-term returns in stocks for 1 year depend on earnings growth and the price paid at entry, so staggering purchases and consulting a SEBI-registered advisor is sensible.\"}},{\"@type\":\"Question\",\"name\":\"Can BHEL become a multibagger from here?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"BHEL has already gained 488.34% in five years, so another multi-fold move would need sustained earnings growth. A multibagger outcome in stocks for 1 year requires earnings to keep growing faster than the market for several years. Net profit has compounded at 37.73% a year since FY22, and FY26 revenue rose 20.08%. At a PE of 52.56 against an industry PE of 45.89, valuation should be checked against that growth before investing.\"}},{\"@type\":\"Question\",\"name\":\"What is the market cap of Divi's Labs, BHEL, BSE and Laurus Labs?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"As of 20 October 2026, Divi's Labs has a market cap of Rs 2,39,982 crore, BHEL has a market cap of Rs 1,51,365 crore, BSE has a market cap of Rs 1,39,823 crore and Laurus Labs has a market cap of Rs 1,09,143 crore. All of them qualify as largecaps. Market cap changes daily with the share price, so check the latest figure on the Univest Screener or on NSE before taking a decision on stocks for 1 year.\"}},{\"@type\":\"Question\",\"name\":\"What are the risks of investing in stocks for 1 year?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"The main risks are market swings, slower growth than expected and valuations that already reflect good news. Companies with strong balance sheets and steady earnings handle these better. Laurus Labs trades at a PE of 100.10 against an industry PE of 36.42, so earnings growth needs to hold up.\"}},{\"@type\":\"Question\",\"name\":\"Why is Laurus Labs trading at a PE of 100.10?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Laurus Labs' PE of 100.10 compares with an industry PE of 36.42. The market is paying a premium for a return on equity of 16.77%, latest-quarter profit growth of 124.73% and FY26 revenue growth of 22.01%, which also means the stock is more sensitive if growth slows. Investors in stocks for 1 year who are comfortable with higher valuation risk may prefer to stagger purchases instead of investing in one go.\"}},{\"@type\":\"Question\",\"name\":\"How much do institutions hold in Divi's Labs, BHEL, BSE and Laurus Labs?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"As of the latest reported quarter, FII and DII together hold 39.55% of Divi's Labs (20.38% and 19.17%), 31.82% of BHEL (9.94% and 21.88%), 45.47% of BSE (21.32% and 24.15%) and 41.74% of Laurus Labs (28.00% and 13.74%). Rising institutional holding is a useful signal in stocks for 1 year, though it should be read with earnings trends rather than on its own.\"}}]}<\/script><\/p>\n","protected":false},"excerpt":{"rendered":"<p>4 largecap stocks for 1 year compared on market cap, PE, ROE, growth and institutional holding: Divi&#8217;s Labs, BHEL, BSE and Laurus Labs.<\/p>\n","protected":false},"author":33,"featured_media":320187,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[845],"tags":[13878,13879],"class_list":["post-320188","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-best-stocks","tag-stocks-for-1-year","tag-stocks-for-1-year-sector"],"metadata":{"rank_math_internal_links_processed":["1"],"_thumbnail_id":["320187"],"rank_math_title":["Stocks For 1 Year 2026: Divi's Labs, BHEL, BSE, Laurus Labs"],"rank_math_description":["Stocks for 1 year to watch for multibagger potential: Divi's Labs, BHEL, BSE and Laurus Labs. Compare market cap, PE, ROE, growth and institutional holding."],"rank_math_focus_keyword":["stocks for 1 year"],"rank_math_robots":["a:2:{i:0;s:7:\"noindex\";i:1;s:8:\"nofollow\";}"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest.in\/blogs-2\/wp-content\/uploads\/2026\/10\/4-largecap-stocks-for-1-year-to-watch-for-future-multibagger-potential-divi-s.webp","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/320188","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/33"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=320188"}],"version-history":[{"count":1,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/320188\/revisions"}],"predecessor-version":[{"id":320189,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/320188\/revisions\/320189"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/320187"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=320188"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=320188"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=320188"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}